
Nuwellis: Enhancing life quality with innovative fluid management solutions for heart conditions.
Nuwellis, founded with a mission to enhance the quality of life for patients suffering from heart failure and fluid overload, focuses on innovative fluid management solutions. The company's flagship product, the Aquadex FlexFlow® System, offers a novel therapy for hypervolemia, particularly for patients who do not find relief from diuretic medications. Nuwellis aims to restore fluid balance and renew hope for patients, placing them at the center of their operations.
Notable figures affiliated with Nuwellis include key medical professionals and investors dedicated to advancing healthcare technologies. The company has achieved significant milestones in patient outcomes, with testimonials highlighting the life-saving impact of the Aquadex system. Through its innovative approach, Nuwellis has made a substantial impact on the treatment of heart-related conditions, improving patient care and quality of life.

Reprieve Cardiovascular
reprievecardio.com

Aqua Heart
aquahrt.com

Fluidnet

NuPulseCV
nupulsecv.com

RenalGuard Solutions
renalguard.com

Flowonix Medical
flowonix.com

CardieX
cardiex.com

Ancora Heart
ancoraheart.com

Nuvaira
nuvaira.com

Cardiac Dimensions

ReliantHeart
reliantheart.com

Respirix

Cardio Flow
cardioflow.net

InvisionHeart
invisionheart.com

NirvaMed
Companies similar to Nuwellis include Reprieve Cardiovascular, Aqua Heart, Fluidnet and NuPulseCV.
Nuwellis was founded in 1999.
Nuwellis' headquarters is located in Eden Prairie, MN, US.
Nuwellis' most recent funding round was for $2.3M (USD) in October 2023.
As of Oct 13, 2023, Nuwellis has raised a total of $2.3M (USD).
Nuwellis has 175 employees as of Feb 6, 2024.